PALOMAR MEDICAL TECHNOLOGIES INC
10-Q/A, 1999-03-03
PRINTED CIRCUIT BOARDS
Previous: PALOMAR MEDICAL TECHNOLOGIES INC, 10-K/A, 1999-03-03
Next: PALOMAR MEDICAL TECHNOLOGIES INC, 10-K/A, 1999-03-03



   
                                 FORM 10-Q/A-3
    

                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   (Mark one)

          [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

                    For quarterly period ended June 30, 1998

                                       OR

         [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

              For the transition period from ________ to ________

                        Commission file number: 0-22340


                       PALOMAR MEDICAL TECHNOLOGIES, INC.
                       ----------------------------------
               (Exact name of issuer as specified in its charter)
<TABLE>
<S>                      <C>                                       <C>         <C>

                         Delaware                                              04-3128178
                         --------                                              ----------
(State or other jurisdiction of incorporation or organization)     (I.R.S. Employer Identification No.)
</TABLE>

               45 Hartwell Avenue, Lexington, Massachusetts 02421
               --------------------------------------------------
                    (Address of principal executive offices)

                                 (781) 676-7300
                                 --------------
                (Issuer's telephone number, including area code)

     Check  whether  the issuer:  (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes X No

     As of July 31, 1998,  65,558,954 shares of Common Stock, $.01 par value per
share, were outstanding.

Transitional Small Business Disclosure Format (check one): Yes    No  X
                                                              ---    ---



<PAGE>


   
                       PALOMAR MEDICAL TECHNOLOGIES, INC.


                                     INDEX


PART IV

        Item 6.  Exhibits and Report on Form 8-K                         P. 1

SIGNATURES                                                               P. 2
    
                                       i
<PAGE>


   
Item 6.  Exhibits and Reports on Form 8-K
- -------  --------------------------------

(a)      Exhibits

*10.1    Second  Amended 1996 Employee  Stock  Purchase Plan (included with Form
         10-Q as filed on August 14, 1998).

 10.2    Amended Second Loan Agreement  between  Palomar  Medical  Technologies,
         Inc. and Coherent, Inc., dated as of May 7, 1998.

*10.3    Loan Agreement between Palomar Medical Technologies, Inc. and Coherent,
         Inc.,  dated May 22,  1998  (included  with Form  10-Q/A-1  as filed on
         November 2, 1998).

*10.4    Fifth  Amendment  to the  Schedule to the Loan and  Security  Agreement
         between Palomar Medical  Technologies,  Inc. and Coast Business Credit,
         dated April 29, 1998  (included with Form 10-Q/A-2 as filed on February
         12, 1999).

*27.1    Financial Data Statement,  Restated, for the period ended June 30, 1997
         (included with Form 10-Q as filed on August 14, 1998).

*27.2    Financial Data Statement,  for the period ended June 30, 1998 (included
         with Form 10-Q as filed on August 14, 1998). 

(b)      Reports on Form 8-K.

         Form 8-K filed June 3, 1998.



*Previously filed.
    
                                       1
<PAGE>



                                   SIGNATURES

         Pursuant  to the  requirements  of the  Securities  Act  of  1934,  the
Registrant  certifies  that it has caused this Report to be signed on its behalf
by the undersigned,  thereunto duly authorized,  in the Town of Lexington in the
Commonwealth of Massachusetts on March 3, 1999.

                                              PALOMAR MEDICAL TECHNOLOGIES, INC.
                                                         (Registrant)




DATE: March 3, 1999                           By:     /s/ Louis P. Valente
                                                   -----------------------
                                                   Louis P. Valente
                                                   Chief Executive Officer
                                                   (Principal Executive Officer)

DATE:  March 3, 1999                                  /s/ Joseph P. Caruso
                                                   -----------------------
                                                   Joseph P. Caruso
                                                   Chief Financial Officer 
                                                   and Treasurer (Principal 
                                                   Financial Officer and 
                                                   Principal Accounting Officer)
                                       2


   
                         AMENDED SECOND LOAN AGREEMENT

         This Amended  Loan  Agreement is dated as of May 7, 1998 by and between
Coherent,  Inc.,  a  Delaware  corporation  ("Coherent"),  and  Palomar  Medical
Technologies, Inc., a Delaware corporation ("PMTI").
    

         Subject to the terms and conditions contained herein, the parties agree
as follows:

         1. Loan. At Coherent's  sole election and  discretion,  Coherent  shall
loan PMTI from time to time  amounts to be agreed  upon  between  them,  to help
finance PMTI's working capital requirements (the "Loans"),  which loans shall be
evidenced by  promissory  notes in the form set forth in Exhibit A (the "Note").
The parties  agree that the  outstanding  loan  balance as of the date hereof is
$1,780,315.22.

         2.  Payment.  In  accordance  with the Sales  Agency,  Development  and
License  Agreement  entered  into  between  parties on  November  17,  1997 (the
"Agreement"),  Coherent  will be using its  reasonable  best  efforts to collect
PMTI's  accounts  receivable that are Collateral for this note. As such accounts
receivable are collected by Coherent,  the amounts due PMTI under the Agreement,
less a one-time 1.5% interest charge,  shall be credited against the outstanding
principal balance of the Note.

         3.  Security  Interest.  PMTI  hereby  creates and grants to Coherent a
security interest in the collateral  described in Section 3 hereof to secure the
payment and performance of the following obligations of PMTI to Coherent:

         (a) Payment of the  indebtedness  evidenced by the Note and any and all
modifications, extensions or renewals thereof,

         (b) Performance and discharge of each and every  obligation,  covenant,
condition and agreement of PMTI herein contained.

   
         4. Collateral. The collateral in which the security interest is created
(the  "Collateral")  shall  consist of those PMTI's  accounts  receivable  where
Coherent has acted as PMTI's  sales agent  pursuant to the  Agreement,  together
with all proceeds thereto.
    

         5.  Recording.  PMTI will execute,  deliver and cause to be recorded or
filed in the manner and place  required by law, any document or instrument  that
may  be  requested  by  Coherent,   including  financing   statements  or  other
instruments of similar  character,  to perfect and protect the lien of this Loan
Agreement upon any and all of the Collateral.

         6. Events of Default.  An Event of Default (as hereinafter  defined) of
any Note issued under this Agreement shall cause all Notes to be immediately due
and  payable.  As  used  herein,  an  "Event  of  Default"  shall  be any of the
following:


<PAGE>

         (a) The failure of PMTI to punctually and properly pay the indebtedness
evidenced by the Note in accordance with its terms.

         (b) The failure of PMTI  punctually  and  properly to observe,  keep or
perform any covenant,  agreement or condition  required to be observed,  kept or
performed by this Agreement.

         (c) The  failure of PMTI to make due and  punctual  performance  of any
covenant,  obligation or agreement in any note, bond, indenture, loan agreement,
note agreement,  mortgage,  security agreement or other instrument evidencing or
related thereto which  constitutes an event of default under any such instrument
(or would give the holder of such instrument the right to accelerate  payment of
such  obligation),  or such  obligation  is not paid as to principal or interest
when due,  and such  default  shall  continue for more than the period of notice
and/or  grace,  if any,  therein  specified  and shall  not have been  waived or
otherwise cured.

         7.  Rights of Secured  Party.  Coherent  shall have all the rights as a
secured party under the laws of California, including the right to sell any part
of the  Collateral  at a public or  private  sale or bid as a  purchaser  of the
Collateral.

         8.  Application  of Proceeds of Sale.  The  proceeds of the sale of any
Collateral sold pursuant to Section 6 hereof shall be applied as follows:

         First:   To the payment of costs and  expenses of such sale,  including
                  the fees and  out-of-pocket  expenses  of counsel  employed in
                  connection  therewith,  and the payment of all other costs and
                  expenses  incurred  by  Coherent  and in  connection  with the
                  administration and enforcement of this Agreement;

         Second:  To the  payment  and  discharge  in  full  of all  obligations
                  described in Section 3 hereof including,  without  limitation,
                  sums then owing in respect of the Note; and

         Third:   The balance (if any) of such  proceeds  shall be paid to PMTI,
                  its  successors  and  assigns,  or  as a  court  of  competent
                  jurisdiction may direct.

         9.  Covenants  of  PMTI.  PMTI  covenants  and  warrants  that,  unless
compliance is waived by Coherent in writing:

         (a) PMTI will immediately notify Coherent of any change in PMTI's name,
identity or corporate structure.

         (b)  PMTI  will  not  further  encumber,  sell,  contract  for  sale or
otherwise  dispose  of any of the  Collateral  until  such time as the  security
interest created by this Agreement has terminated.

         (c) PMTI will take all actions necessary or appropriate to preserve and
defend its title to the  Collateral and the validity of the lien created by this
Agreement.

         (d) PMTI will  promptly  notify  Coherent in writing of any event which
materially  and adversely  affects the ability of PMTI or Coherent to dispose of
the  Collateral,  or the rights or remedies  of  Coherent  in relation  thereto,
including,  but not  limited  to,  the levy of any  legal  process  against  the
Collateral.
<PAGE>

         (e) PMTI will,  without expense to Coherent,  do, execute,  acknowledge
and deliver, or cause to be done, executed, acknowledged and delivered, all such
further  acts and  instruments  as Coherent  shall from time to time  require in
order to facilitate the performance of this Agreement.

         10. Miscellaneous.

         (a) No failure or delay by Coherent in exercising  any right,  power or
privilege hereunder shall operate as a waiver thereof,  and no single or partial
exercise thereof shall preclude any other of further exercise of the exercise of
any other right, power or privilege.

         (b) Should any one or more of the provisions hereof be determined to be
illegal or  unenforceable,  all other  provisions  hereof  shall be give  effect
separately therefrom and shall not be affected thereby.

         (c) The security  interest  created by this Loan Agreement  shall fully
terminate  immediately upon the full and complete  satisfaction and discharge of
all of the Obligations set forth in paragraph 3 hereof.  Upon such  termination,
Coherent shall execute and deliver to PMTI such termination statements and other
instruments of release of such security interest as PMTI may reasonably require.

         (d) All notices,  requests,  demands and other communications hereunder
shall be in writing and shall be deemed to have been duly given if  delivered or
mailed first class,  postage prepaid,  to the parties at the following addresses
(or such  other  address  as shall be given in  writing  by either  party to the
other):

        To Coherent:

                Coherent, Inc.
                5100 Patrick Henry Drive
                Santa Clara, CA  95054
                Attn:  General Counsel
                Facsimile No.:  (408) 970-9998

        To PMTI:

                Palomar Medical Technologies, Inc.
                45 Hartwell Avenue
                Lexington, MA  02173
                Attn:  General Counsel
                Facsimile No.:   (781) 676-7377 

         (e) This Loan  Agreement  and security  interest  created  hereby shall
inure  to the  benefit  of the  Coherent,  its  successor  and  assigns  and any
transferee of any of the Obligations  secured hereby,  and shall be binding upon
PMTI and its successors and heirs.

         (f) The laws of the State of  California  shall  govern the validity of
this  Agreement,  the  construction of its terms and the  interpretation  of the
rights and duties of the parties.
<PAGE>

         The foregoing  Agreement is hereby  executed as of the date first above
written.

                        COHERENT, INC.
                        a Delaware corporation



                        By:  
                            -------------------
                        Title:                 
                              -----------------

                        PALOMAR MEDICAL TECHNOLOGIES, INC.
                        a Delaware corporation



                        By:                                
                           --------------------------------
                        Title:                             
                              -----------------------------

<PAGE>


                                                                       EXHIBIT A
                                                                              to
                                                                    Exhibit 10.2

                                PROMISSORY NOTE

$__________                                              Santa Clara, California
                                                            ______________, 1998

         FOR VALUE RECEIVED,  the  undersigned,  Palomar  Medical  Technologies,
Inc., a Delaware  corporation  ("PMTI"),  promises to pay to  Coherent,  Inc., a
Delaware corporation ("Coherent"), or order, the principal sum of Dollars ($ ).

         In accordance with the Sales Agency,  Development and License Agreement
entered into between  parties on November 17, 1997 (the  "Agreement"),  Coherent
will be using its reasonable best efforts to collect PMTI's accounts  receivable
that  collateralize  this note. As such accounts  receivable are collected,  the
amounts due PMTI under the  Agreement,  less a one-time  1.5%  interest  charge,
shall be credited against the outstanding  principal  balance of this promissory
note. This Note shall be immediately due and payable in the Event of Default (as
defined in the Agreement).

         PMTI shall reimburse Coherent for all costs and expenses incurred by it
and shall pay the reasonable  fees and  disbursements  of counsel to Coherent in
connection with the enforcement of Coherent's rights hereunder.

         No amendment,  modification or waiver of any provision of this Note nor
consent to any departure by PMTI  therefrom  shall be effective  unless the same
shall be in writing and signed by Coherent and then such waiver or consent shall
be  effective  only in the specific  instance  and for the specific  purpose for
which given.

         PMTI hereby  waives any  requirement  of notice of dishonor,  notice of
protest and protest.

         This Note shall be deemed to be a  contract  made under the laws of the
State of California  and shall be construed in accordance  with the laws of said
State.  This Note shall be binding upon PMTI and its  successors and assigns and
the terms hereof shall inure to the benefit of Coherent and its  successors  and
assigns,  including  subsequent  holders hereof. The holding of any provision of
this Note to be invalid or  unenforceable  by a court of competent  jurisdiction
shall not  affect any other  provisions  and the other  provisions  of this Note
shall remain in full force and effect.

         This Note is secured with certain  collateral  pursuant to the terms of
the Loan Agreement.  A description of the accounts receivables  constituting the
collateral for this promissory note is set forth on the attached Schedule A.

                PALOMAR MEDICAL TECHNOLOGIES, INC.


                By:                               
                   -------------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission